Patients with atopic dermatitis are prone to
S.aureus colonization and infection. Recent studies showed the high rate of
S.aureus colonization in these patients, especially in AD skin lesions and the nasal cavity, which ranged between 76–100%, compared to 2–25% in healthy subjects (
9-
11). This is likely the result of a combination of host factors including skin barrier dysfunction as well as impaired host immune responses in AD (
12,
13). Comparing the above-mentioned studies, we found lower rate of overall
S.aureus colonization in our patients (47%). Lo et al. (
14) in Taiwan found that
S.aureus colonization rates were 50% in their patients which is similar to our results.
Our study showed a higher rate of
S.aureus colonization in the nasal cavity and AD lesions compared to healthy skin (44%, 36%, and 21%, respectively). Nasal carriage of
S.aureus in the general population is approximately 10–45% and is higher among patients with AD (39–100%) (
15,
16). In our study, among positive cultures, MRSA accounted for 33% of all
S.aureus isolates. Recent trends indicate an increasing incidence of CA-MRSA (community-associated MRSA) in the general population (
17), and some studies have showed the high rate of MRSA in AD (
14,
18,
19). A study by Lo et al. have shown that 60% of
S.aureus isolates from 20 children with AD and skin and soft-tissue infections were classified as MRSA but the percentage of MRSA isolates among all
S.aureus-colonizing isolates was 28.3% (
14).
Ortega-Loayza et al. analyzed 141 cultures from 93 pediatric dermatology patients in North Carolina, where 66% of the cultures that had been taken from children with atopic dermatitis.
S.aureus was recovered from 97 cultures of which 32% were MRSA (
19). Schlievert et al. have recently tested a small group of AD isolates for methicillin resistance
S.aureus and have found that 25% were MRSA (
18). Chung et al. in a South Korean clinic noted a 75.4% incidence rate of
S.aureus colonization in children with atopic dermatitis, with 18.3% incidence of CA-MRSA in skin lesions (
20).
Some studies have shown lower colonization rate for MRSA. In a study done by Huang et al. on 31 patients with AD, 7.4% of AD skin lesions and 4% of the nares with positive cultures for
S.aureus were resistant to methicillin (
21).
Our results revealed significant correlation between SCORAD score and colonization with
S.aureus in AD skin lesions and the nasal cavity (P = 0.001). Some other studies have found that the severity of dermatitis correlates with the density of
S.aureus colonization on AD skin lesions and anti
S.aureus antibiotics have been shown to mitigate the severity of AD (
22,
23). Kedzierska et al. in 87 AD patients showed a positive correlation between the colonization density of
S.aureus in AD skin lesions and the severity of AD, and they reported no significant correlation between density of bacteria in healthy skin and SCORAD (
24). Hon et al. also found that the anterior nares are an important site for
S.aureus and that nasal colonization was associated with more extensive lesions and a higher SCORAD index (
25). The authors in one study have suggested that the production of inflammatory cytolysins and high-level superantigens by CA-MRSA increases their ability to cause extensive AD infections (
18).
Tomi et al. and Zoller et al. have shown that the increased AD severity correlates with the presence of a super antigen produced by
S.aureus (
25-
27). However, our study could not conclude a relationship between type of
S.aureus (MSSA or MRSA) and SCORAD index since we found MRSA just in moderate SCORAD and none of the isolated
S.aureus in severe and mild groups were MRSA. One study designed by Chiu et al. to determine the distribution of the bacterial virulence factors (such as; toxic shock syndrome toxin, staphylococcal enterotoxins A–E, G–K, enterotoxin gene cluster egc, exfoliatin A, B, and D) and their correlation with disease severity in 34 patients with AD, have shown that patients with a moderate SCORAD were more likely to be colonized by enterotoxin B-positive
S.aureus (P = 0.027) and no virulence factor was significantly associated with a severe SCORAD (
16). We are not sure exactly the reason of the lack of MRSA in patients with severe SCORAD, but certain reasons can be suggested. There were only a few patients with MRSA and the number of patients was not similar in each level of severity. We did not match for age in different groups of severity. One retrospective study in children with atopic dermatitis has shown that the prevalence of MRSA is increased in children older than 5 years (
28). Other research without these limitations may help to clarify the significance of this abnormal finding.
In conclusion, our data shows lower rate of S.aureus colonization in AD patients but a similar rate of MRSA colonization in comparison with former studies. In our study the patients with moderate SCORAD had a higher rate of MRSA colonization. We did not have a control group in our study and also do not know about S.aureus colonization rate in our general population. More research with a control group and larger sample sizes would be supportive for identification of the exact relationship between MR pattern and SCORAD index in atopic dermatitis.